Merestinib Active Not Recruiting Phase 2 Trials for Metastatic Cancers / Cancer, Advanced / Biliary Tract Cancer Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02711553A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer